|Slideshows|October 3, 2019

8 examples of how GBCA improves MRI

Author(s)Ilana Cass, MD, Rola Saouaf, MD

Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Matthew Nudy, MD, discusses breast arterial calcification and cardiovascular risk

ByMatthew Nudy, MD

December 8th 2025

Image Credit: © lordn - stock.adobe.com.

International group publishes first clinical guidance on polygenic risk scores for breast cancer

ByMorgan Ebert, Managing Editor

April 1st 2025

Image credit: © Gorodenkoff - stock.adobe.com

Wendie Berg, MD, PhD, discusses new breast density guidelines

ByMorgan Ebert, Managing Editor

September 11th 2024

Reducing geriatric breast cancer screening through cessation messaging

ByCeleste Krewson, Assistant Editor

August 27th 2024

Alzheimer disease risk reduced by hormone therapy for breast cancer treatment

ByCeleste Krewson, Assistant Editor

July 16th 2024

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

8 examples of how GBCA improves MRI

Newsletter

Related Content

Matthew Nudy, MD, discusses breast arterial calcification and cardiovascular risk

International group publishes first clinical guidance on polygenic risk scores for breast cancer

Wendie Berg, MD, PhD, discusses new breast density guidelines

Reducing geriatric breast cancer screening through cessation messaging

Alzheimer disease risk reduced by hormone therapy for breast cancer treatment

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Justin Drake, PhD, discusses the latest research on a protein-based liquid biopsy to detect early breast cancer

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

Brexanolone shows rapid, sustained relief in postpartum depression

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

Beyond Vasomotor Symptoms: The Potential Role of NK Receptor Antagonism in Mood and Sleep